Are you Dr. Xie?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 14 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
4207 E Cotton Center Blvd.
Building 10
Phoenix, AZ 85040Phone+1 888-276-2223Fax+1 972-767-0225
Summary
- Dr. Qingmei Xie, MD is a board certified pathologist in Phoenix, Arizona. She is currently licensed to practice medicine in Arizona, Washington, and Indiana.
Education & Training
- Creighton University School of Medicine (Omaha)Residency, Pathology-Anatomic and Clinical, 2006 - 2006
- Montefiore Medical Center/Albert Einstein College of MedicineFellowship, Hematopathology, 2005 - 2006
- Creighton University School of Medicine (Omaha)Residency, Pathology-Anatomic and Clinical, 2001 - 2005
- Tongji Medical UniversityClass of 1987
Certifications & Licensure
- AZ State Medical License 2009 - 2027
- WA State Medical License 2022 - 2026
- TX State Medical License 2010 - 2026
- FL State Medical License 2010 - 2026
- IA State Medical License 2008 - 2026
- NE State Medical License 2006 - 2026
- NC State Medical License 2010 - 2025
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Hematopathology
- Join now to see all
Publications & Presentations
PubMed
- 15 citationsPlasmablastic transformation of low-grade CD5+ B-cell lymphoproliferative disorder with MYC gene rearrangements.Zenggang Pan, Qingmei Xie, Susan Repertinger, Bill G. Richendollar, Wing C. Chan
Human Pathology. 2013-10-01 - 46 citationsArray-Based Karyotyping for Prognostic Assessment in Chronic Lymphocytic Leukemia: Performance Comparison of Affymetrix 10K2.0, 250K Nsp, and SNP6.0 ArraysJill M. Hagenkord, Federico A. Monzon, Shera Kash, Stan L. Lilleberg, Qingmei Xie
The Journal of Molecular Diagnostics. 2010-03-01 - 37 citationsPodoplanin (d2-40): a new immunohistochemical marker for reactive follicular dendritic cells and follicular dendritic cell sarcomas.Qingmei Xie, Lugen Chen, Kai Fu, Josephine Harter, Ken H. Young
International Journal of Clinical and Experimental Pathology. 2008-01-01